877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, matrixscientific.com, Antineoplastic drugs, Cyclic compounds

Categories

Antineoplastic and immunomodulating drugs (1)
Cycloalkanes (1)
Cyclopropanes (1)
Experimental cancer drugs (1)
Halides (1)
Organofluorides (1)
Organohalides (1)
Pharmaceuticals (1)
Piperazines (1)
Six-membered rings (1)
Tetracyclic compounds (1)
Three-membered rings (1)

Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related searches
Polycyclic organic compounds
matrixscientific.com
Antineoplastic drugs
Cyclic compounds